Elenco

  • “Studio multicentrico nazionale per la valutazione della potenza analitica di un metodo di dosaggio delle sostanze d’abuso in matrice cheratinica” – C.Leonardi, C.Assi, C.Bandini, N.Broccoli, C.D’Angelo, P.F.D’Egidio, I.Dell’Eva, N.Della Torre, E.Faedda, M.Gottardi, P.Laurenzi, M.Lodolini, M.Calligara, F.Lodi, A.Lotti, R.Lovaste, M.Miozzo, F.Nava, C.Pieri, L.Rocchi, G.Ventre, F.Svaizer, A.Lucchini.
  • “Buprenorphine detection in hair samples by immunometric screening test: preliminary experience” – F.Svaizer, A.Lotti, M.Gottardi and M.Miozzo (LIESP – Azienda Provinciale per i Servizi Sanitari, Trento – Italy).
  • “High throughput analysis of drugs of abuse in hair by combining purposely designed sample extraction compatible with immunometric methods used for drug testing in urine” – R.de la Torre, E.Civit, (IMIM Hospital del Mar, Univ.Pompeu Fabra – Barcelona, Spain), F.Svaizer, A.Lotti, M.Gottardi and M.Miozzo (LIESP – Azienda Provinciale per i Servizi Sanitari, Trento – Italy).
  • “Analisi della ricaduta in termini operativi ed economici dell’introduzione di un test di screening immunometrico per indagini tossicologiche su matrice cheratinica: confronto con la tecnica gascromatografica con rilevazione in spettrometria di massa” – A.Colatutto, G.M.Guarrera, G.Zumerle, L.De Luca, P.Sala (Az.Osp.Univ. “S.Maria della Misericordia” di Udine – Italy).
  • Oral fluid and hair in workplacedrug testing programs: new technology for immunoassays – Christine Moore (Immunalysis Corporation, 829 Towne Center Drive, Pomona, CA 91767, USA).
  • “Analysis of drugs of abuse in hair: evaluation of the immunochemical method VMA-T vs. LC-MS/MS or GC-MS” – M.R. Baumgartner, R. Guglielmello, M. Fanger and T. Kraemer (Institute of Legal Medicine, University of Zurich, Zurich – Switzerland).
  • “Approccio alla ottimizzazione dei valori di cut-off per un test di screening immunometrico su matrice cheratinica per le comuni droghe d’abuso” – Antonio Colatutto, Barbara Marcon, Luca Isola, Rodolfo Zaglia, Pierguido Sala (Dipartimento di Medicina di Laboratorio, SOC Laboratorio Analisi di Elezione, Azienda Ospedaliero Universitaria S. Maria della Misericordia, Udine – Italy), Nicoletta Soldà (Istituto di Medicina Legale, Università degli Studi, Udine – Italy).
  • “Drugs of abuse and psychotropic substances in hair: a new and rapid screening method” – S. Vezzoli, S. Manzoni, M. Bernini and L. Zanola (Department of Legal Medicine, University of Brescia – Italy), M. Gottardi and A. Lotti (Laboratorio di Sanità Pubblica (LSP), Azienda Provinciale per i Servizi Sanitari, Trento – Italy).
  • “Rapid extraction, identification and quantification of drugs of abuse in hair by immunoassay and ultra-performance liquid chromatography tandem mass spectrometry” – S.Pichini, E.Marchei, M.Pellegrini, M.Rotolo and R.Pacifici (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy), M.Gottardi and F.Svaizer (Laboratorio di Sanità Pubblica (LSP), Azienda Provinciale per i Servizi Sanitari, Trento – Italy).
  • “A Review of Methodology for Testing Hair for Cocaine” – Rebekah Harrison and Shanlin Fu (Centre for Forensic Science, University of Technology, Sydney (UTS), Ultimo, NSW 2007 – Australia).
  • “Assessment of Unsuspected Exposure to Drugs of Abuse in Children from a Mediterranean City by Hair Testing” – Simona Pichini, Emilia Marchei, Manuela Pellegrini, Maria Concetta Rotolo and Roberta Pacifici (Drug Abuse and Doping Unit, Department of Therapeutic Research and Medicines Evaluation, National Institute of Health, Rome – Italy), Oscar Garcia-Algar and Airam Alvarez (Unitat de Recerca Infància i Entorn (URIE), Paediatric Service, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain), Massimo Gottardi and Fiorenza Svaizer (Laboratorio di Sanità Pubblica (LSP), Azien¬da Provinciale per i Servizi Sanitari, Trento – Italy).
  • “Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers” – Simona Pichini, Emilia Marchei, Rita Di Giovannandrea and Roberta Pacifici (Drug Abuse and Doping Unit, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome – Italy),Oscar García-Algar and Arelis Gomez (Unitat de Recerca Infància I Entorn (URIE), Paediatric Service, Institut de Recerca Hospital delMar – IMIM, Barcelona – Spain).
  • “Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone” – Simona Pichini, Maria Concetta Rotolo and Roberta Pacifici (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy), Jordi García and Oscar García-Algar (Unitat de Recerca Infància I Entorn (URIE), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain), Noelia Girona and Lorna Leal (CAS Baluard, Agència de Salut Pública de Barcelona Service, Managed by Associació Benestar i Desenvolupament, Barcelona – Spain).
  • “Identification and quantification of THC-COOH glucuronide in hair by ultra-performance liquid chromatography tandem mass spectrometry” – S.Pichini, E.Marchei, M.Pellegrini and R.Pacifici (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy), S.Martello and M.Chiarotti (Università Cattolica del Sacro Cuore – Policlinico Agostino Gemelli, Rome – Italy), M.Gottardi, F.Svaizer and A.Lotti (Laboratorio di Sanità Pubblica (LSP), Azienda Provinciale per i Servizi Sanitari, Trento – Italy).
  • “La matrice cheratinica: perchè è conveniente nei Ser.D” – Massimo Gottardi e Andrea Lotti (Laboratorio di Sanità Pubblica (LSP), Azienda Provinciale per i Servizi Sanitari, Trento – Italy) – (Comedical s.r.l., Trento – Italy).
  • “Application of biochip array technology to the multiplex detection of drugs of abuse in hair samples” – Anderson V., Smyth S., Darragh J., McConnell R.I. and FitzGerald S.P. (Randox Toxicology, 30 Cherryvalley Road, Crumlin, BT29 4QN – United Kingdom).
  • “Hair Analysis in Clinical and Forensic Toxicology”- Pascal Kintz (Istitute of Legal Medicine , Univerity of Strasbourg, Strasbourg, France), Alberto Salomone (Centro Regionale Antidoping e di Tossicologia “A. Bertinaria” Orbassano (TO), Italy), Marco Vincenti (Dipartimento di Chimica, Università di Torino, Turin, Italy – Centro Regionale Antidoping e di Tossicologia “A. Bertinaria” Orbassano (TO)).
  • “Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium” – Xavier Joya and Judith Salat-Batlle (Unitat de Recerca Infància I Entorn (URIE), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain) – (Red de Salud Materno-Infantil y del Desarrollo (SAMID), Programa RETICS, Instituto Carlos III, Madrid – Spain), Emilia Marchei, Valeria Calvaresi and Roberta Pacifici (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy), Óscar Garcia-Algar (Unitat de Recerca Infància I Entorn (URIE), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain) – (Red de Salud Materno-Infantil y del Desarrollo (SAMID), Programa RETICS, Instituto Carlos III, Madrid -Spain) – (Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona – Spain).
  • “Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption” – Xavier Joya and Judith Salat-Batlle (Unitat de Recerca Infància I Entorn (URIE), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain) – (Red de Salud Materno-Infantil y del Desarrollo (SAMID), Programa RETICS, Instituto Carlos III, Madrid – Spain), Oscar García-Algar (Unitat de Recerca Infància I Entorn (URIE), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain) – (Red de Salud Materno-Infantil y del Desarrollo (SAMID), Programa RETICS, Instituto Carlos III, Madrid – Spain) – (Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona (UAB), Bellaterra – Spain), Emilia Marchei, Valeria Calvaresi, Roberta Pacifici and Simona Pichini (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy).
  • “Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of antidepres¬sant and anxiolytic drugs in neonatal meconium and maternal hair” – Simona Pichini, Emilia Marchei, Renata Solimini and Roberta Pacifici (Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanitá, Rome – Italy), Laura Cortes and M. Dolores Gomez-Roig (Servicio de Obstetricia y Ginecología, Hospital Sant Joan de Déu, BCNatal, Hospital Sant Joan de Déu-Hospital Clínic, Barcelona – Spain) – (Red SAMID, RETICs, Instituto de Salud Carlos III, Madrid – Spain) – (Departamemnto de Obstetricia y Ginecología, Pediatría, Radiología y Anatomía, Universidad de Barcelona – Spain), Oscar García-Algar (Red SAMID, RETICs, Instituto de Salud Carlos III, Madrid – Spain) – (Grup de Recerca Infancia i Entorn (GRIE), Instituto Hospital del Mar de Investigaciones Medicas (IMIM), Barcelona – Spain).
  • “Segmental hair testing to disclose chronic exposure to psychoactive drugs” – Emilia Marchei, Ilaria Palmi, Simona Pichini and Roberta Pacifici (Drug Abuse and Doping Unit, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome – Italy), Ileana-Rita Anton Airaldi, Juan Antonio Costa Orvay, Joan García Serra and Bartolomé Bonet Serra (Paediatrics Unit, Hospital Can Misses, Eivissa – Spain), Oscar García-Algar (Grup de Recerca Infància i Entorn (GRIE), Paediatrics Unit, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona – Spain).
  • “Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursorsand metabolites in different specimens: application to clinical and forensic cases” Francesco Paolo Busardò (Unit of Forensic Toxicology (UoFT), Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, V. Le Regina Elena 336, 00161 Rome – Italy), Chrystalla Kyriakoua and Daniel Sejer Pedersen (Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology, Jagtvej 162, University of Copenhagen, 2100 Copenhagen – Denmark), Emilia Marchei, Roberta Pacifici and Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, V. le Regina Elena 299, 00161 Rome – Italy).
  • “Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide, and morphine-6-glucuronide in human hair from opioid users by LC-MS/MS” – Megan Grabenauer, Nichole D. Bynum, Katherine N. Moore, Robert M. White and John M. Mitchell (Center for Forensic Sciences, RTI International, Research Triangle Park, NC – USA), Eugene D. Hayes, Ronald Flegel (Substance Abuse and Mental Health Services Administration, Rockville, MD – USA).
  • “Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex” – Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy), Anastasio Tini (Unit of Forensic Toxicology Università La Sapienza, Rome, Italy), Adele Minutillo (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Ascanio Sirignano (School of Law – University of Camerino, Italy), Emilia Marinelli, Simona Zaami (Unit of Forensic Toxicology (UoFT).
  • “Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails” – Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy), Anastasio Tini (Unit of Forensic Toxicology Università La Sapienza, Rome, Italy), Claudia Mortali (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Raffaele Giorgetti, Adriano Tagliabracci (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy).
  • “Nails Analysis for Drugs Used in the Context of Chemsex: A Pilot Study” – Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy), Roberta Pacifici (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Maria Rosaria Varì (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Anastasio Tini (Unit of Forensic Toxicology Università La Sapienza, Rome, Italy), Anna Rita Volpe (Laboratory of Pharmacology and Toxicology, Department of Life, Health and Environmental Sciences, University of L’Aquila, Via Verbio 67100, Coppito AQ, Italy), Raffaele Giorgetti (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy).
  • “Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair” – Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Jeremy Carlier (Unit of Forensic Toxicology Università La Sapienza, Rome, Italy), Raffaele Giorgetti, Adriano Tagliabracci (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Roberta Pacifici (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Massimo Gottardi, Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy).
  • “Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) analysis of psychoactive drugs in oral fluid” – Sara Malaca (Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, Covilhã, Portugal; Laboratório de Fármaco-Toxicologia; UBIMedical, Universidade da Beira Interior, Covilhã, Portugal), Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy), Simona Pichini, Emilia Marchei (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy).
  • “Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of “Light Cannabis” Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use” – Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Giulio Mannocchi (University of Camerino, Camerino, Italy), Paolo Berretta (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Simona Zaami (Unit of Forensic Toxicology (UoFT), Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Rome) , Filippo Pirani (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Roberta Pacifici (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy).
  • “Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual” – Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Giulio Mannocchi (University of Camerino, Camerino, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy), Ana Pilar Pérez-Acevedo, Lourdes Poyatos, Esther Papaseit, Clara Pérez-Mañá, Magì Farré (Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTiP-IGTP, Badalona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Cerdantola del Vallés, Spain), Roberta Pacifici (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy).
  • “Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases” – Giulio Mannocchi (University of Camerino, Camerino, Italy), Annagiulia Di Trana, Anastasio Tini (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy), Simona Zaami (Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University, Rome, Italy), Massimo Gottardi (Comedical S.r.l., Trento, Italy), Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy).
  • “Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid” – Emilia Marchei (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Sara Malaca (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy)., Graziano Silvia (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Massimo Gottardi (Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 29, 38123, Trento, Italy) and, Simona Pichini (National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy), Francesco Paolo Busardò (Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy).
 

Sei un operatore sanitario?

I contenuti presenti nella pagina che segue contengono informazioni rivolte esclusivamente agli OPERATORI SANITARI, in quanto si riferiscono a prodotti rientranti nella categoria dei dispositivi medici che richiedono l’impiego o l’intervento da parte di professionisti del settore medico-sanitario.
Conferma di essere un operatore sanitario utilizzando i pulsanti sottostanti.

Are you an Healthcare professional?

The contents on the following page contain information addressed exclusively to HEALTHCARE PROFESSIONALS, as they refer to products included in the category of medical devices that require the use or intervention of medical professionals.
Confirm that you are a healthcare professional using the buttons below.